CRA consultants Ann Baker, Matthew Majewski, and Andrew Parece provide insight on various life sciences innovation topics including breaking barriers and creating value. Their comments appear in the April 2016 Celebrating Innovation special issue of PharmaVOICE. To read more, click the link below.
France’s temporary authorisation (ATU) programme: reform implications
The temporary authorisation for use (Autorisation Temporaire d’Utilisation, ATU) programme in France is intended to provide early access to medicines for...